Sutro biopharma

Sutro Biopharma is working independently and with partners to develop novel cancer therapies, including antibody-drug conjugates, bispecific antibodies and cytokine derivatives targeting immuno-oncology pathways. Many thanks to our Sutro team for their continuous sutro biopharma in placing our patients first.

Skip to main content. Sutro Biopharma, Inc. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. Vaxcyte, Inc.

Sutro biopharma

Key events shows relevant news articles on days with large price movements. Gossamer Bio Inc. GOSS 4. Kezar Life Sciences Inc. KZR 0. Ovid Therapeutics Inc. OVID 0. Vaxcyte Inc. PCVX 0. Trevi Therapeutics Inc. TRVI 2. XOMA Corp. XOMA 1. Coherus Biosciences Inc.

Dedicated to our Patients and Changing the Future of Oncology. Learn More.

Sutro Biopharma, Inc. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in STRO is an ADC targeting folate receptor alpha , a cell-surface protein highly expressed in gynecological cancers. As of [update] Sutro's drug discovery efforts have focused on antibody-drug conjugates, cytokine -based immuno-oncology therapies, and bispecific antibodies primarily directed at clinically-validated targets for which the current standard of care is suboptimal.

Sutro Biopharma is working independently and with partners to develop novel cancer therapies, including antibody-drug conjugates, bispecific antibodies and cytokine derivatives targeting immuno-oncology pathways. Many thanks to our Sutro team for their continuous efforts in placing our patients first. We appreciate and value all the work you have done! To read the report, click the link. Dedicated to our Patients and Changing the Future of Oncology. Learn More.

Sutro biopharma

Sutro Biopharma, Inc. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in STRO is an ADC targeting folate receptor alpha , a cell-surface protein highly expressed in gynecological cancers. As of [update] Sutro's drug discovery efforts have focused on antibody-drug conjugates, cytokine -based immuno-oncology therapies, and bispecific antibodies primarily directed at clinically-validated targets for which the current standard of care is suboptimal. In July , Sutro signed a collaboration and licensing agreement with Merck to discover and develop novel cytokine-based therapies for cancer and autoimmune disorders. In , Sutro and Celgene announced they had refocused their immuno-oncology collaboration on four programs advancing through preclinical development, including an ADC program targeting B-Cell maturation antigen BCMA. Sutro was named one of Fierce Biotech's Fierce 15 in Contents move to sidebar hide.

Nude hippie chicks

Download as PDF Printable version. Trevi Therapeutics Inc. Sutro Biopharma is working independently and with partners to develop novel cancer therapies, including antibody-drug conjugates, bispecific antibodies and cytokine derivatives targeting immuno-oncology pathways. CTMX 0. You may be interested in info This list is generated from recent searches, followed securities, and other activity. Total number of common shares outstanding as of the latest date disclosed in a financial filing. Cash from investing. Net profit margin. Vistagen Therapeutics Inc. To read the report, click the link.

.

Listed exchange for this security. Founded in under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Hidden categories: Articles with short description Short description is different from Wikidata Articles needing additional references from April All articles needing additional references Articles containing potentially dated statements from All articles containing potentially dated statements Articles with ISNI identifiers. Total assets The total amount of assets owned by a company. About Us. Collaborating with Local Community Organizations Together, we can make a difference. First 1 2 3 4 5 Next Last. The range between the high and low prices over the past 52 weeks. The amount by which a company's cash balance increases or decreases in an accounting period.